Page last updated: 2024-11-07

metaraminol and Cardiomyopathies

metaraminol has been researched along with Cardiomyopathies in 2 studies

Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pissarek, M1
Ermert, J1
Oesterreich, G1
Bier, D1
Coenen, HH1
Boldy, M1
Ellestad, MH1
Kemp, GL1

Other Studies

2 other studies available for metaraminol and Cardiomyopathies

ArticleYear
Relative uptake, metabolism, and beta-receptor binding of (1R,2S)-4-(18)F-fluorometaraminol and (123)I-MIBG in normotensive and spontaneously hypertensive rats.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:3

    Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Animals; Autoradiography; Cardiomyopathies; Hear

2002
The use of metaraminol in the evaluation of mitral insufficiency.
    Diseases of the chest, 1969, Volume: 55, Issue:4

    Topics: Adolescent; Adult; Aged; Blood Pressure; Capillaries; Cardiac Catheterization; Cardiomegaly; Cardiom

1969